EU-LIFE supports OA to scholarly publications recognizing the rights to every scientist and citizen to access scientific literature (publishing as well as reading and re-using) as we believe science to be a public good for society.
OA implementation requires innovation and a well-thought plan engaging all different actors worldwide. Importantly, OA implementation must ensure high-level quality and fairness of the scientific publication system.
EU-LIFE puts forward 10 key recommendations on the implementation of Plan S.
On July 25th, the Court of Justice of the European Union (ECJ) ruled that organisms obtained by modern forms of mutagenesis such as CRISPR are not exempt from the EU GMO legislation. Consequently, genome edited organisms must comply with the strict conditions of the EU GMO legislation. This is in stark contrast with the opinion of the Advocate-General of the Court, which was published in January of this year and advised ruling otherwise.
EU-LIFE institutes we urge politicians from all Members States and the European Union institutions to unequivocally support the ERC namely by increasing its budget in the next framework programme the FP9 and clearly endorsing its guiding principles of scientific merit and independence.
EU-LIFE, released today a statement with its recommendations for next framework Programme for Research & Innovation, FP9. Strong key message is: to drive European leadership in innovation, boost excellent ground breaking research in combination with professional technology transfer.
EU-LIFE congratulate Commissioner Moedas and DG Research for initiating the public debate regarding the creation of an EIC and would like to highlight the potential of an EIC as an extraordinary opportunity for a paradigm shift at two levels:
To change the way innovation is tackled in Europe
To change the vision of the role of research in boosting innovation